TLR2 and schistosomiasis: While our data suggest that targeted TLR2 signaling inhibitors may have therapeutic effect during the acute phases of schistosomiasis, further study is still required to address the role of TLR2 signaling to better understand the potential benefits of its inhibitors in treatment of chronic disease and delineate novel insight into the immune interplay underlying schistosomiasis.